Markets:

Overview

News

Currencies

International

Treasuries

Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (NY:ENZ)

0.3138 UNCHANGED

Last Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

< Previous 1 2 3 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 17, 2023

The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!

Via InvestorPlace

Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket ↗

March 17, 2023

Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp.

Via Benzinga

Why Enzo Biochem Stock Is Skyrocketing After Hours ↗

March 16, 2023

Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 16, 2023

Via Benzinga

Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying ↗

January 20, 2023

The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...

Via Benzinga

Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying ↗

January 19, 2023

The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Nasdaq Rises 100 Points; Gold Gains Over 1% ↗

December 13, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday

Via Benzinga

Dow Turns Lower; Crude Oil Rises Sharply ↗

December 13, 2022

U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

December 13, 2022

On Tuesday, 49 companies hit new 52-week lows.

Via Benzinga

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 13, 2022

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

Via Benzinga

Earnings Scheduled For December 12, 2022 ↗

December 12, 2022

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is projected to report earnings for its second quarter.

Via Benzinga

Earnings Scheduled For October 14, 2022 ↗

October 14, 2022

Companies Reporting Before The Bell • Wells Fargo (NYSE:WFC) is estimated to report quarterly earnings at $1.08 per share on revenue of $18.77 billion.

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

Earnings Scheduled For June 9, 2022 ↗

June 09, 2022

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report quarterly loss at $0.05 per share on revenue of $14.64 million.

Via Benzinga

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 03, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 25, 2022

Via Benzinga

Earnings Scheduled For March 14, 2022 ↗

March 14, 2022

Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street ↗

December 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug...

Via Benzinga

The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO ↗

December 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron...

Via Benzinga

Earnings Scheduled For December 15, 2021 ↗

December 15, 2021

Companies Reporting Before The Bell • Toro (NYSE:TTC) is estimated to report quarterly earnings at $0.53 per share on revenue of $955.53 million. • REV Group (...

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 19, 2021

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 13, 2021

Gainers Revance Therapeutics (NASDAQ:RVNC) stock moved upwards by 17.79% to $24.09 during Wednesday's pre-market session. The company's market cap stands at $1.7...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 12, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP...

Via Benzinga

Enzo Biochem Clocks 27% Revenue Growth In Q4, Margin Remains Stable ↗

October 12, 2021

Biosciences and diagnostics company Enzo Biochem Inc (NYSE: ENZ) reported fourth-quarter FY21 revenue growth of 27% year-on-year to $24.8 million. Revenue...

Via Benzinga

Earnings Scheduled For October 12, 2021 ↗

October 12, 2021

Companies Reporting Before The Bell • AZZ (NYSE:AZZ) is likely to report quarterly earnings at $0.62 per share on revenue of $219.95 million. • Fastenal (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...

Via Benzinga

The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More ↗

October 03, 2021

Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (NY:ENZ)

Headline News about Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Starting at $3.75/week.

Subscribe Today